Table 2. Diagnostic accuracy, etiological accuracy, clues and response time according to group and application moment. Curitiba, PR, Brazil, 2020.
| Phases/Groups | Intervention Group - (n=27) | Control Group - (n=24) | p-value‡‡ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| M* | SD† | SD‡ | Q1§ | Q3|| | M* | SD† | SD‡ | Q1§ | Q3|| | ||
| Diagnostic accuracy | G¶:0.390; T**:0.041; I††:0.270 | ||||||||||
| Phase 1 | 2.04 | 2.34 | 3.00 | -1.00 | 4.00 | 3.09 | 1.73 | 4.00 | 3.00 | 4.00 | |
| Phase 2 | 1.93 | 2.13 | 3.00 | -1.00 | 4.00 | 1.67 | 2.57 | 3.00 | -1.00 | 4.00 | |
| Etiological accuracy | G: 0.905; T: 0.122; I: 0.003 | ||||||||||
| Phase 1 | 3.59 | 1.19 | 3.00 | 3.00 | 5.00 | 3.21 | 0.59 | 3.00 | 3.00 | 3.00 | |
| Phase 2 | 3.04 | 0.65 | 3.00 | 3.00 | 3.00 | 3.38 | 0.71 | 3.00 | 3.00 | 3.25 | |
| Clues | G: 0.211; T: 0.896; I: 0.678 | ||||||||||
| Phase 1 | 4.22 | 1.42 | 4.00 | 3.00 | 5.00 | 4.75 | 1.48 | 4.50 | 4.00 | 6.00 | |
| Phase 2 | 4.15 | 1.85 | 5.00 | 3.00 | 5.00 | 4.62 | 1.56 | 4.00 | 3.75 | 6.00 | |
*M = Mean; †SD = Standard Deviation; ‡Md = Median; §Q1 = First quartile; ||Q3 = Third quartile; ¶G = Groups; **T = Time; ††I = Interaction; ‡‡Non-parametric ANOVA test for repeated measures